BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37909979)

  • 21. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.
    Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D
    J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma.
    Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K
    Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53-Armed Oncolytic Virotherapy Improves Radiosensitivity in Soft-Tissue Sarcoma by Suppressing BCL-xL Expression.
    Komatsubara T; Tazawa H; Hasei J; Omori T; Sugiu K; Mochizuki Y; Demiya K; Yoshida A; Fujiwara T; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
    Acta Med Okayama; 2024 Apr; 78(2):151-161. PubMed ID: 38688833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.
    Yokoyama T; Iwado E; Kondo Y; Aoki H; Hayashi Y; Georgescu MM; Sawaya R; Hess KR; Mills GB; Kawamura H; Hashimoto Y; Urata Y; Fujiwara T; Kondo S
    Gene Ther; 2008 Sep; 15(17):1233-9. PubMed ID: 18580968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy.
    Tazawa H; Hasei J; Yano S; Kagawa S; Ozaki T; Fujiwara T
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32085583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus.
    Hashimoto M; Kuroda S; Kanaya N; Kadowaki D; Yoshida Y; Sakamoto M; Hamada Y; Sugimoto R; Yagi C; Ohtani T; Kumon K; Kakiuchi Y; Yasui K; Kikuchi S; Yoshida R; Tazawa H; Kagawa S; Yagi T; Urata Y; Fujiwara T
    Br J Cancer; 2024 Apr; 130(7):1187-1195. PubMed ID: 38316993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined oncolytic adenovirus carrying MnSOD and mK5 genes both regulated by survivin promoter has a synergistic inhibitory effect on gastric cancer.
    Liu SS; Hu JQ; Gu JF; Ni AM; Tang WH; Liu XY
    Neoplasma; 2022 Jan; 69(1):36-48. PubMed ID: 34881625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression.
    Fujiwara H; Kubota T; Amaike H; Inada S; Takashima K; Atsuji K; Yoshimura M; Maemondo M; Narumi K; Nukiwa T; Matsumoto K; Nakamura T; Hagiwara A; Yamagishi H
    Cancer Gene Ther; 2005 Feb; 12(2):206-16. PubMed ID: 15486556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo.
    Das S; Somasundaram K
    Cancer Biol Ther; 2006 Feb; 5(2):210-7. PubMed ID: 16481734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
    Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
    Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect.
    Xu H; Shen Z; Xiao J; Yang Y; Huang W; Zhou Z; Shen J; Zhu Y; Liu XY; Chu L
    BMC Cancer; 2014 Sep; 14():668. PubMed ID: 25220382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
    Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
    Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.
    Muhammad T; Sakhawat A; Khan AA; Ma L; Gjerset RA; Huang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):190. PubMed ID: 31238944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model.
    Huang P; Watanabe M; Kaku H; Kashiwakura Y; Chen J; Saika T; Nasu Y; Fujiwara T; Urata Y; Kumon H
    Cancer Gene Ther; 2008 May; 15(5):315-22. PubMed ID: 18274558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.
    Koo T; Choi IK; Kim M; Lee JS; Oh E; Kim J; Yun CO
    Hum Gene Ther; 2012 Jun; 23(6):609-22. PubMed ID: 22248367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers.
    Wang X; Su C; Cao H; Li K; Chen J; Jiang L; Zhang Q; Wu X; Jia X; Liu Y; Wang W; Liu X; Wu M; Qian Q
    Mol Cancer Ther; 2008 Jun; 7(6):1598-603. PubMed ID: 18566230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models.
    Sasaki Y; Negishi H; Idogawa M; Suzuki H; Mita H; Toyota M; Shinomura Y; Imai K; Tokino T
    Mol Cancer Ther; 2008 Apr; 7(4):779-87. PubMed ID: 18413792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of natural killer cells in adenovirus-mediated p53 gene therapy.
    Carroll JL; Nielsen LL; Pruett SB; Mathis JM
    Mol Cancer Ther; 2001 Nov; 1(1):49-60. PubMed ID: 12467238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.